Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01488747 · ClinicalTrials.gov registry record · NA
Bioavailability of Fish Oils: Emulsified Versus Capsular Triglyceride
A NA study, sponsored by USDA Grand Forks Human Nutrition Research Center.
- Completed
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT01488747: Completed NA study, sponsored by USDA Grand Forks Human Nutrition Research Center.
NCT01488747 is a NA study that has completed, run by USDA Grand Forks Human Nutrition Research Center. The registered enrollment target is 19 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01488747, a NA study, has completed, sponsored by USDA Grand Forks Human Nutrition Research Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
The primary objective of this investigation is to determine the relative percentage and rate of incorporation of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and total omega-3 (n-3) fatty acids after ingestion of 4 emulsified flavored triglyceride fish oil supplements versus an encapsulated triglyceride in defined plasma lipid pools. The primary endpoints to be evaluated include the fatty acid composition of plasma lipids before and after consumption of a single dose of emulsified triglyceride based fish oil and triglyceride of similar n-3 compositions in capsule form. The investigators will measure changes in plasma phospholipid, and chylomicron fatty acids.
Primary Outcome
Evaluation of the bioavailability of fatty acids from fish oil supplements
Interventions
- DIETARY_SUPPLEMENT Coromega Omega-3 Squeeze
- DIETARY_SUPPLEMENT Coromega Nectar
- DIETARY_SUPPLEMENT Barleans Swirl
- DIETARY_SUPPLEMENT Nordic Omega-3 Softgel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2011-11 |
| Est. Completion | 2016-04 |
| Phase | NA |
What the finished NCT01488747 record still lists
NCT01488747 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 4 interventions - of which Coromega Omega-3 Squeeze is the first listed.
NCT01488747 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01488747 about?
NCT01488747 is a clinical study titled "Bioavailability of Fish Oils: Emulsified Versus Capsular Triglyceride". The primary objective of this investigation is to determine the relative percentage and rate of incorporation of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and total omega-3 (n-3) fatty acids after ingestion of 4 emulsified flavored triglyceride fish oil supplements versus an encapsulat...
What is the current status of trial NCT01488747?
This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2011-11. Estimated completion is 2016-04.
What interventions are being tested in trial NCT01488747?
The interventions under investigation include: Coromega Omega-3 Squeeze (DIETARY_SUPPLEMENT), Coromega Nectar (DIETARY_SUPPLEMENT), Barleans Swirl (DIETARY_SUPPLEMENT), Nordic Omega-3 Softgel (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01488747?
This trial is sponsored by USDA Grand Forks Human Nutrition Research Center, which has 57 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01488747's enrollment target sits among peer trials
19 1861st of 2000 higher than 138 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia